PREVPAC (COPACKAGED) Drug Patent Profile
✉ Email this page to a colleague
When do Prevpac (copackaged) patents expire, and when can generic versions of Prevpac (copackaged) launch?
Prevpac (copackaged) is a drug marketed by Takeda Pharms Usa and is included in one NDA.
The generic ingredient in PREVPAC (COPACKAGED) is amoxicillin; clarithromycin; lansoprazole. There are forty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amoxicillin; clarithromycin; lansoprazole profile page.
Summary for PREVPAC (COPACKAGED)
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PREVPAC (COPACKAGED) at DailyMed |
-patent-expirations.png "PREVPAC (COPACKAGED) drug patent expirations")
Anatomical Therapeutic Chemical (ATC) Classes for PREVPAC (COPACKAGED)
US Patents and Regulatory Information for PREVPAC (COPACKAGED)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | PREVPAC (COPACKAGED) | amoxicillin; clarithromycin; lansoprazole | CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL | 050757-001 | Dec 2, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PREVPAC (COPACKAGED)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | PREVPAC (COPACKAGED) | amoxicillin; clarithromycin; lansoprazole | CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL | 050757-001 | Dec 2, 1997 | ⤷ Sign Up | ⤷ Sign Up |
| Takeda Pharms Usa | PREVPAC (COPACKAGED) | amoxicillin; clarithromycin; lansoprazole | CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL | 050757-001 | Dec 2, 1997 | ⤷ Sign Up | ⤷ Sign Up |
| Takeda Pharms Usa | PREVPAC (COPACKAGED) | amoxicillin; clarithromycin; lansoprazole | CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL | 050757-001 | Dec 2, 1997 | ⤷ Sign Up | ⤷ Sign Up |
| Takeda Pharms Usa | PREVPAC (COPACKAGED) | amoxicillin; clarithromycin; lansoprazole | CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL | 050757-001 | Dec 2, 1997 | ⤷ Sign Up | ⤷ Sign Up |
| Takeda Pharms Usa | PREVPAC (COPACKAGED) | amoxicillin; clarithromycin; lansoprazole | CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL | 050757-001 | Dec 2, 1997 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PREVPAC (COPACKAGED)
See the table below for patents covering PREVPAC (COPACKAGED) around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Germany | 3750431 | ⤷ Sign Up | |
| European Patent Office | 0174726 | PYRIDINE DERIVATIVES AND THEIR PRODUCTION | ⤷ Sign Up |
| Denmark | 171340 | ⤷ Sign Up | |
| Canada | 1255314 | DERIVES DE 2-(PYRID-2-YL)-METHYLTHIO(OU METHYLSULFINYL)BENZIMIDAZOLE ET LEUR PREPARATION (2-(PYRID-2-YL)-METHYLTHIO(OR METHYLSULFINYL) BENZIMIDAZOLE DERIVATIVES AND THEIR PRODUCTION) | ⤷ Sign Up |
| Spain | 546152 | ⤷ Sign Up | |
| Hungary | 195210 | PROCESS FOR PRODUCING PYRIDINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS COMPRISING THESE COMPOUNDS AS ACTIVE SUBSTANCE | ⤷ Sign Up |
| Bulgaria | 61202 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for PREVPAC (COPACKAGED)
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0174726 | SPC/GB94/011 | United Kingdom | ⤷ Sign Up | SPC/GB94/011, EXPIRES: 20051210 |
| 0174726 | 93C0021 | Belgium | ⤷ Sign Up | PRODUCT NAME: LANSOPRAZOLE; NAT. REG.: 150 S 539 F 4 19921119; FIRST REG.: FR 333 412.1 19901211 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
